| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Raj Vivek | Director | C/O PERIMETER SOLUTIONS, INC., 8000 MARYLAND AVE., SUITE 350, CLAYTON | /s/ Noriko Yokozuka, as Attorney-in-Fact | 02 Mar 2026 | 0001708641 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PRM | Stock Option (right to buy) | Award | $0 | +6,194 | $0.000000 | 6,194 | 26 Feb 2026 | Common Stock | 6,194 | $11.80 | Direct | F1 | |
| transaction | PRM | Stock Option (right to buy) | Award | $0 | +7,000 | +100% | $0.000000 | 14,000 | 26 Feb 2026 | Common Stock | 7,000 | $5.23 | Direct | F2 |
| transaction | PRM | Stock Option (right to buy) | Award | $0 | +7,000 | +50% | $0.000000 | 21,000 | 26 Feb 2026 | Common Stock | 7,000 | $8.88 | Direct | F3 |
| transaction | PRM | Stock Option (right to buy) | Award | $0 | +7,000 | +33% | $0.000000 | 28,000 | 26 Feb 2026 | Common Stock | 7,000 | $12.09 | Direct | F4 |
| transaction | PRM | Stock Option (right to buy) | Award | $0 | +1,750 | +33% | $0.000000 | 7,000 | 26 Feb 2026 | Common Stock | 1,750 | $11.80 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | On February 12, 2025, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2025, 2026, 2027, 2028 and 2029. The performance criteria for 2025 were partially met, resulting in the vesting of the option as to 6,194 shares of common stock. |
| F2 | On February 14, 2024, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2024, 2025, 2026, 2027 and 2028. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. |
| F3 | On February 15, 2023, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2023, 2024, 2025, 2026 and 2027. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. |
| F4 | On January 28, 2022, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. |
| F5 | On December 7, 2021, the reporting person was granted an option to purchase 8,750 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2025 were met, resulting in the vesting of the option as to 1,750 shares of common stock. |